OpenVSafe by OpenVAERS
Search V-safe

G3X-21945-88901

3 vaccinations 4 coded responses 18 check-ins 4 free-text entries 3 call cases
Sex
Female
Age at first dose
56-60
ZIP prefix
208 / MD
Registered
2020-12-29
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-29
    Registered in v-safe
  2. 2020-12-29
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-29
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  4. 2020-12-30
    Survey response — days 1–6 daily, dose 1
    MedDRA: Adverse reaction — Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Have not felt this all day but during a period around 2 pm to 4ish. Temp check was at 2:30 pm. Only temp reading this far
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2020-12-30
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  6. 2020-12-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  7. 2021-01-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  8. 2021-01-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  9. 2021-01-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Muscle or body aches
    Adult check-in
  10. 2021-01-05
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-01-16
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-01-21
    Dose 2 — Pfizer-BioNTech
  13. 2021-01-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  14. 2021-01-28
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-02-04
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  16. 2021-02-11
    Health check-in — day 21, dose 2
    Feeling: Fair
    Adult check-in
  17. 2021-02-18
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-02-27
    Survey response — day 35, dose 2
    MedDRA: Fatigue, Muscle spasms, Muscle twitching, Paraesthesia — Feeling: Fair · Be unable to work
    Free text: Extreme fatigue with tingling/twitching extremities and muscle spasms.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-03-04
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-04-22
    Survey response — 3 months, dose 2
    MedDRA: Asthenia, Dizziness, Fatigue, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Symptoms: Occasional recurring Extreme fatigue with weakness and lightheaded ness/dizziness. · Healthcare visit (other): Visit to primary care and rheumatologist.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-04-22
    Report sent to call center — 3 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  22. 2021-06-08
  23. 2021-07-24
    Survey response — 6 months, dose 2
    MedDRA: Cardiolipin antibody positive, Fatigue, Fibrin D dimer increased, Malaise, Musculoskeletal stiffness, Pain in extremity, Self-medication, Unevaluable event — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Symptoms: Pain, often excruciating, in legs (especially left) in foot and arms. Periods of extreme fatigue. Stiffness in hands and toes. Doesnt respond to pain meds or heat. Elevated anticardiolipin Ab IgM and d dimer. Not feeling well. · Healthcare visit (other): Scheduling follow up with primary care doc
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  24. 2021-07-24
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  25. 2021-07-29
  26. 2021-10-05
    Dose 3 — Pfizer-BioNTech
  27. 2022-01-22
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-29Pfizer-BioNTech
22021-01-21Pfizer-BioNTech
32021-10-05Pfizer-BioNTech No

Call center

3 call center cases

2 unsuccessful · 1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-30

Systemic reaction (other): Have not felt this all day but during a period around 2 pm to 4ish. Temp check was at 2:30 pm. Only temp reading this far

Release 4 — day 35, dose 2

2021-02-27

Symptoms: Extreme fatigue with tingling/twitching extremities and muscle spasms.

Release 7 — 3 months, dose 2

2021-04-22

Symptoms: Occasional recurring Extreme fatigue with weakness and lightheaded ness/dizziness.
Healthcare visit (other): Visit to primary care and rheumatologist.

Release 9 — 6 months, dose 2

2021-07-24

Symptoms: Pain, often excruciating, in legs (especially left) in foot and arms. Periods of extreme fatigue. Stiffness in hands and toes. Doesnt respond to pain meds or heat. Elevated anticardiolipin Ab IgM and d dimer. Not feeling well.
Healthcare visit (other): Scheduling follow up with primary care doc

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit ✓ ✓ ✓
HCVOUnevaluable event ✓ · ✓
SDAsthenia ✓ ✓ ✓
SDCardiolipin antibody positive ✓ · ✓
SDDizziness ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDFibrin D dimer increased ✓ · ✓
SDMalaise ✓ · ✓
SDMuscle spasms ✓ ✓ ✓
SDMuscle twitching ✓ ✓ ✓
SDMusculoskeletal stiffness ✓ · ✓
SDPain in extremity ✓ · ✓
SDParaesthesia ✓ ✓ ✓
SDSelf-medication ✓ · ✓
SROAdverse reaction ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release